Overall, these findings suggest that an increase in immune cells promoting tumor angiogenesis and a decrease in immune cells inhibiting tumor angiogenesis in the TRIP6 high expression group exacerbate the progression of cancer, leading to unfavorable tumor prognosis. Here, TRIP6 is linked to cancer.